
EORTC-NCI-ASCO invites the submission of abstracts for posters.
IMPORTANT DATES Online Abstract Submission OPENS on 29 April 2009 (3 AM CET) Online Late Breaking(*) Abstract Submission OPENS on 7 July 2009 (3 AM CET) |
IMPORTANT INFORMATION
The 3 best posters will be selected for oral presentations
Authors are encouraged to submit topics in the follow categories:
- Clinical application of cancer biomarkers: Blood/Serum-based molecular markers
- Clinical application of cancer biomarkers: Tissue-based molecular markers
- Pharmacogenomics & pharmacogenetics
- Ethical, legal and regularory issues in biomarker research
- New assessment criteria for clinico-genomic trials
- Can we obtain the most from the least tissue?
- Cancer stem cells: ready for the clinic?
- Successful clinico-genomic trials: How to run them?
Accepted abstracts submitted
by 3 July 2009:
Will be published in “European Journal of Cancer”, the Abstract / Proceeding book of the conference.
Submitters will receive an email with result of the review and the Scientific Committee’s decision in August 2009.
from 7 July 2009(*):
Will NOT be presented at the meeting.
Submitters will receive an email with result of the review and the Scientific Committee’s decision in August 2009.
Late Breaking Abstract will only be considered for cases in which the study was not closed or the data were not available in time for online abstract submission (29 April to 3 July 2009).
The online abstract submission procedure will NOT accept abstracts that exceed 2500 characters.
Abstracts sent by mail, fax or e-mail will NOT be accepted.
Please read CAREFULLY the Abstracts Submission Regulations and Guidelines before submitting your abstract.
For any further information regarding abstract submission, please contact: |
EORTC is partially supported by the Belgian National Lottery and by the Belgian Federal Science Policy Office